Advance Search

Dampak Pandemi COVID-19 Terhadap Keberhasilan Pengobatan Tuberkulosis: Scoping Review

DOI: https://doi.org/10.20956/mff.v27i01.3...
Article History

Submited : September 11, 2023
Published : September 12, 2023

Keywords:
Tuberkulosis (TB) merupakan penyakit infeksi yang memberikan beban pembiayaan kesehatan yang besar bagi negara. Pasien TB merupakan pasien yang perlu mendapatkan perhatian khusus untuk pengobatannya karena durasi pengobatan yang cukup lama yaitu minimal enam bulan. Kondisi pandemi COVID-19 dapat berdampak pada pelaksanaan pengobatan TB di sarana pelayanan kesehatan. Kajian ini bertujuan untuk mengevaluasi dampak pandemi COVID-19 terhadap hasil pengobatan pasien TB. Metode: Pendekatan scoping review dilakukan dalam penulisan artikel ini. Penelusuran literatur dilakukan melalui pangkalan data PubMed, ScienceDirect, dan SpringerLink, menggunakan kata kunci tuberculosisAND ("treatment outcome" OR "therapy outcome") AND (covid OR pandemic) yang diseleksi berdasarkan batasan yang telah ditetapkan. Artikel hasil pencarian disusun menggunakan EndNote X9. Berdasarkan hasil penelusuran, didapatkan sembilan artikel penelitian observasional. Pengobatan TB dikatakan berhasil jika subjek penelitian dinyatakan sembuh atau pengobatan lengkap. Hasil pengobatan TB pada periode sebelum dibandingkan dengan selama pandemi COVID-19 pada lima negara menunjukkan adanya penurunan angka keberhasilan terapi, yaitu Malawi (Lilongwe) 0,1%; China 1,0%; China (Ningxia Hui) 2,53%; Korea 5,9%; Etiopia 8,03%; dan Zimbabwe (Harare) 11,6%. Akan tetapi, dua penelitian di Kenya (Nairobi) dan Sierra Leone, Afrika menunjukkan peningkatan keberhasilan terapi TB selama masa pandemi secara berturut-turut, yaitu 2% dan 8,9%. Tren hasil pengobatan TB selama masa pandemi COVID-19 menunjukkan hasil yang variatif, namun mayoritas penelitian menunjukkan penurunan keberhasilan di beberapa negara.

References

  1. Silva S, Arinaminpathy N, Atun R, Goosby E, Reid M. Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis [published correction appears in Lancet Glob Health. 2021 Nov;9(11):e1507]. Lancet Glob Health. 2021;9(10):e1372-e1379. doi:10.1016/S2214-109X(21)00299-0
  2. Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, et al. Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts. Int J Infect Dis. 2021;113 Suppl 1(Suppl 1): S7-S12. doi: 10.1016/j.ijid.2021.02.107
  3. Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 2016;63(7):e147-e195. doi:10.1093/cid/ciw376
  4. Mirzayev F, Viney K, Linh NN, Gonzalez-Angulo L, Gegia M, Jaramillo E, et al. World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update. Eur Respir J. 2021;57(6):2003300. Published 2021 Jun 4. doi:10.1183/13993003.03300-2020
  5. Aznar ML, Espinosa-Pereiro J, Saborit N, Jové N, Sánchez Martinez F, Pérez-Recio S, et al. Impact of the COVID-19 pandemic on tuberculosis management in Spain. Int J Infect Dis. 2021;108:300-305. doi:10.1016/j.ijid.2021.04.075
  6. Rodrigues I, Aguiar A, Migliori GB, Duarte R. Impact of the COVID-19 pandemic on tuberculosis services. Pulmonology. 2022;28(3):210-219. doi:10.1016/j.pulmoe.2022.01.015
  7. World Health Organization (WHO). Tuberculosis control : the DOTS strategy (Directly Observed Treatment Short-Course) [Internet]. World Health Organization; 1997 [cited 2022 Aug 12]. Report No.: WHO/TB/97.228. Available from: https://apps.who.int/iris/handle/10665/63548
  8. Kemenkes RI. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis - TBC Indonesia [Internet]. [cited 2022 Aug 24]. Available from: https://tbindonesia.or.id/pustaka/pedoman/umum/pedoman-nasional-pelayanan-kedokteran-tata-laksana-tuberkulosis/
  9. Thekkur P, Tweya H, Phiri S, Mpunga J, Kalua T, Kumar AMV, et al. Assessing the Impact of COVID-19 on TB and HIV Programme Services in Selected Health Facilities in Lilongwe, Malawi: Operational Research in Real Time. Trop Med Infect Dis. 2021;6(2):81. Published 2021 May 19. doi:10.3390/tropicalmed6020081
  10. Fei H, Yinyin X, Hui C, Ni W, Xin D, Wei C, et al. The impact of the COVID-19 epidemic on tuberculosis control in China. Lancet Reg Health West Pac. 2020;3:100032. doi:10.1016/j.lanwpc.2020.100032
  11. Wang X, He W, Lei J, Liu G, Huang F, Zhao Y. Impact of COVID-19 Pandemic on Pre-Treatment Delays, Detection, and Clinical Characteristics of Tuberculosis Patients in Ningxia Hui Autonomous Region, China. Front Public Health. 2021;9:644536. Published 2021 May 21. doi:10.3389/fpubh.2021.644536
  12. Min J, Ko Y, Kim HW, Koo HK, Oh JY, Jeong YJ, et al. Increased Healthcare Delays in Tuberculosis Patients During the First Wave of COVID-19 Pandemic in Korea: A Nationwide Cross-Sectional Study. J Korean Med Sci. 2022;37(3):e20. Published 2022 Jan 17. doi:10.3346/jkms.2022.37.e20
  13. Mohammed H, Oljira L, Roba KT, Yimer G, Fekadu A, Manyazewal T. Containment of COVID-19 in Ethiopia and implications for tuberculosis care and research. Infect Dis Poverty. 2020;9(1):131. Published 2020 Sep 16. doi:10.1186/s40249-020-00753-9
  14. Gandhi AP, Kathirvel S, Rehman T. Effect of COVID-19 lockdown on the pathway of care and treatment outcome among patients with tuberculosis in a rural part of northern India: a community-based study. J Rural Med. 2022;17(2):59-66. doi:10.2185/jrm.2021-039
  15. Thekkur P, Takarinda KC, Timire C, Sandy C, Apollo T, Kumar AMV, et al. Operational Research to Assess the Real-Time Impact of COVID-19 on TB and HIV Services: The Experience and Response from Health Facilities in Harare, Zimbabwe. Trop Med Infect Dis. 2021;6(2):94. Published 2021 May 31. doi:10.3390/tropicalmed6020094
  16. Mbithi I, Thekkur P, Chakaya JM, Onyango E, Owiti P, Njeri NC, et al. Assessing the Real-Time Impact of COVID-19 on TB and HIV Services: The Experience and Response from Selected Health Facilities in Nairobi, Kenya. Trop Med Infect Dis. 2021;6(2):74. Published 2021 May 10. doi:10.3390/tropicalmed6020074
  17. Lakoh S, Jiba DF, Baldeh M, Adekanmbi O, Barrie U, Seisay AL, et al. Impact of COVID-19 on Tuberculosis Case Detection and Treatment Outcomes in Sierra Leone. Trop Med Infect Dis. 2021;6(3):154. Published 2021 Aug 19. doi:10.3390/tropicalmed6030154
  18. Maher D, Floyd K, Sharma BV, Jaramillo E, Nkhoma W, Nyarko E, et al. Community contribution to TB care : practice and policy [Internet]. World Health Organization; 2003 [cited 2022 Aug 12]. Report No.: WHO/CDS/TB/2003.312. Available from: https://apps.who.int/iris/handle/10665/67865
  19. Alipanah N, Jarlsberg L, Miller C, Linh NN, Falzon D, Jaramillo E, et al. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies. PLoS Med. 2018;15(7):e1002595. Published 2018 Jul 3. doi:10.1371/journal.pmed.1002595
  20. Genet C, Melese A, Worede A. Effectiveness of directly observed treatment short course (DOTS) on treatment of tuberculosis patients in public health facilities of Debre Tabor Town, Ethiopia: retrospective study. BMC Res Notes. 2019;12(1):396. Published 2019 Jul 12. doi:10.1186/s13104-019-4424-8
  21. Zimmer AJ, Heitkamp P, Malar J, Dantas C, O’Brien K, Pandita A, et al. Facility-based directly observed therapy (DOT) for tuberculosis during COVID-19: A community perspective. J Clin Tuberc Other Mycobact Dis. 2021;24:100248. Published 2021 Jun 25. doi:10.1016/j.jctube.2021.100248
  22. Jaiswal S, Sharma H, Joshi U, Agrawal M, Sheohare R. Non-adherence to anti-tubercular treatment during COVID-19 pandemic in Raipur district Central India. Indian J Tuberc. 2021. Available online 9 Sept 2021. https://doi.org/10.1016/j.ijtb.2021.08.033
  23. Klinton JS, Heitkamp P, Rashid A, Faleye BO, Htat HW, Hussain H, et al. One year of COVID-19 and its impact on private provider engagement for TB: A rapid assessment of intermediary NGOs in seven high TB burden countries. J Clin Tuberc Other Mycobact Dis. 2021;25:100277. doi:10.1016/j.jctube.2021.100277
Risna, H. W., Nisa Maria, & Kartika Citra Dewi Permata Sari. (2023). Dampak Pandemi COVID-19 Terhadap Keberhasilan Pengobatan Tuberkulosis: Scoping Review. Majalah Farmasi Dan Farmakologi, 27(3), 26-31. https://doi.org/10.20956/mff.v27i01.30041

Copyright (c) 2023 Array

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Downloads

Download data is not yet available.
Fulltext
pdf